hygiene, and can be iatrogenically injured during dental treatment procedures, oral manifestations of PG have been reported rarely and mainly as isolated cases in the scientific literature. This paucity of identified cases suggests that many cases may have been undiagnosed or misdiagnosed (Fig. 1) . For a dental practitioner treating a patient known to have PG, the risk of triggering oral lesions of PG secondary to mucosal injury is unknown. Furthermore, if oral PG lesions were to develop, they would need to be accurately differentiated from other oral ulcerative conditions, such as major aphthae, traumatic ulcerative granuloma with stromal eosinophilia (TUGSE), neutropenic ulcers, manifestations of infectious diseases or oral squamous cell carcinoma, amongst others, in order to be properly managed.
In an effort to provide a detailed explanation of the oral manifestations of PG, a systematic search was conducted using medical databases. This article presents the pertinent diagnostic criteria, discusses the differential diagnosis and therapeutic modalities for PG involving the oral cavity.
Search Strategy
A thorough search using the PubMed and Embase databases was executed between September 1st 2015 and February 5th 2016. The combination of MeSh terms "Oral" and "Pyoderma Gangrenosum" was entered in the search fields. The reference list of each article was searched for any prior unidentified cases. Considering the rare occurrence of oral lesions in patients diagnosed with PG, it was impossible to assess articles based on methods of randomization, patient selection, or blinding. No limitations on language or date of publication were imposed. None of the articles included in this review revealed any source of bias or conflict of interest. The quality of articles was assessed based on the rigor of the diagnostic methods, histopathological analysis of biopsied specimens, detailed therapeutic management, and patient follow-up. Only lesions clinically resembling PG and properly diagnosed by methods of exclusion were included in the qualitative analysis. Considering the non-specificity of the histopathologic appearance of these lesions, the absence of biopsies of oral ulcers was not considered as a criterion of exclusion in this review. However, it was considered an element reinforcing the diagnosis of PG by excluding certain similar pathologies [2] . Based upon these requirements, 10 cases were excluded from this review [6, [12] [13] [14] [15] . The following Prisma Flow Chart exhibits the selection methodology (Fig. 2) .
Results
A review of the English and French-language literature revealed 20 acceptable cases of intraoral PG. The important features of these cases, as reported in individual case reports, are summarized in Table 1 . The clinical and epidemiological data is summarized in Table 2 .
Discussion Oral Manifestations of PG
Epidemiological data was available for all patients with intraoral PG. The average age was 48.7 years (±21.86 years). Men were affected more frequently than women, with 65% (13/20) of reported intraoral PG cases affecting males. Oral lesions were reported in the absence of concomitant cutaneous involvement in 20.0% (4/20) of cases [14, [16] [17] [18] . The most frequent sites were the tongue, buccal mucosa and soft palate, together representing 67.6% (23/34) of all reported oral lesions. Other lesions involved the hard palate, oropharynx, lip, commissure, gingiva, and retromolar area [5, 14, 16, 17, 19, 20] . Generally, mucosal lesions in the oral cavity were smaller than skin lesions, measuring between 1 and 5 cm in greatest diameter [5, 14, 18, [21] [22] [23] [24] [25] [26] [27] . As with skin lesions, the onset is rapid and ulcers develop over the course of 4-8 Fig. 1 This 67-year-old white male presented a thin leukoplakic lesion on the posterior dorsal tongue. His medical history included hypertension, diabetes and dyslipidemia, for which he took rovustatin, metformin and olmesartan. He reported a 20 pack-year smoking history, having quit smoking 2-months prior, and consumed 6 beers/ week for the last 40 years. The lesion was biopsied and diagnosed as hyperkeratosis with focal mild epithelial dysplasia and no evidence of candidiasis. At the 1-week post-op examination, he presented normal healing of the biopsy site. One month later, he presented to the emergency dental clinic complaining of tongue discomfort. A large necrotic ulcer at the site of the biopsy was noted (picture). There was no purulence or submandibular lymphadenopathy. A second biopsy of the border of the ulcer was signed out as a non-specific ulcer. The patient was prescribed Chlorhexidine 0.12% rinses BID and clindamycin 500 mg TID × 14 days. The lesion healed gradually over the next 2 months. Shortly after, he was diagnosed with primary lung cancer (the patient did not know which type) weeks [12, 14] . Initially, red colored nodules or papulopustules can develop. As they rupture, irregularly shaped, painful ulcerations are created. Ulcers present irregular, rolled-out margins and a necrotic, grey or tan colored base. The base of the lesion can be granular and friable leading to frequent bleeding [14] . The edges can be elevated and PG ulcers are often bordered by an erythematous or violaceous halo underlining the inflammatory nature of these lesions [21, 28] . Certain ulcers are covered by an overlying yellow pseudomembrane, and may express purulent discharge [21, 24, 29] . Lesions on the lips can exhibit crusting [16, 29] . Supplementary images of oral PG ulcers showing the variety of morphologic features can be visualized in the case reports [5, 10, [20] [21] [22] [23] 29] . Oral and skin lesions in PG are non-indurated. They can be tender to palpation. Pain, dysphagia, sore throat and difficulty in movement are frequently reported complaints with oral PG. In more extensive cases, bone loss and destruction of the periodontal support of adjacent teeth have been reported [14, 24] .
Histopathology
Biopsies of oral PG show non-specific histopathological features. Diagnosis is therefore based on the clinical features and exclusion of other causes of oral ulceration. In a case series involving 16 patients with cutaneous PG, 83% of cases were diagnosed based on the clinical features and the exclusion of infectious and neoplastic causes [4] . Reports of extensive ulceration bordered by an overlying fibrinopurulent membrane with heavy neutrophilic infiltration of the lamina propria are consistently seen in biopsied cases [5, 12, 16, 18, 23, 24, 26, [29] [30] [31] [32] . Neutrophils can have an altered appearance [20] . A mixed inflammatory cell infiltrate comprised of polymorphonuclear neutrophils, lymphocytes, histiocytes, and plasma cells is also reported. Infiltration of lymphocytes can extend into the underlying skeletal muscle [26] . Granulation tissue can be identified when chronic inflammation is present. Vasculitis was observed in one biopsied specimen [10] . However, it is suggested that the presence of vasculitis is secondary to heavy inflammation and is not a direct consequence of PG [8] . Perivascular hyalinization, fibrin deposition, hemorrhage and leukocytoclasia can be present in some lesions [12] . Almost half of microbiological cultures obtained from cutaneous and mucosal ulcers associated with PG are negative for infectious agents [3, 17] . However, secondary infections are common; therefore, a positive culture cannot exclude PG. Immunofluorescence analysis is inconclusive, and does not constitute a useful diagnostic test due to the absence of a humoral autoimmune process in this disease.
Underlying Systemic Diseases Associated with PG
80% (16/20) of patients with oral PG have an underlying systemic disease. Most of these cases (6/16) were associated with inflammatory bowel disease (IBD). In fact, PG is an extra-intestinal manifestation in up to 1% of patients with IBD [1] . Other underlying systemic conditions include rheumatoid arthritis, monoclonal gammopathy, myeloproliferative conditions, and other hematological disorders [1, 9, [33] [34] [35] .
Some cases of cutaneous PG, sometimes accompanied by oral lesions, have been observed in patients with chronic hepatitis [36] , acute or chronic leukemia [2, 8, 9, 33, 35] , polycythemia rubra vera [10, 25] and refractory anemia [17] . PG was the initial manifestation of leukemia in some cases [35] . Furthermore, in 10-20% of cases, an association with paraproteinaemia was identified [3, 5, 30] .
Recently, PG has been included in two distinct autoinflammatory syndromes, PAPA and PASH [37] . PAPA syndrome results from mutations in the proline-serinethreonine-phosphatase interactive protein 1 (PSTPIP1) and CD2-binding protein 1 (CD2BP1) genes, which cause a triad of pyogenic arthritis, PG and acne [35, 38] . The PASH triad is composed of PG, acne, and suppurative hidradenitis. Recent studies have revealed a heterozygous missense mutation for c.1213 C > T in the PSTPIP1 gene and an increased number of repetitions of the CCTG microsatellite motif in the in the promoter region of this gene in patients with PASH syndrome [37, 39] . Marzano et al. also reported a p.E277D missense mutation of the PSTPIP1 gene in a patient with PA-PASH syndrome (associated pyogenic arthritis) [40] . To date, oral PG lesions have not been reported in the context of theses syndromes.
Although there is no specific diagnostic test for PG, some non-specific markers of inflammation have been found to be elevated in affected patients. Elevated erythrocyte sedimentation rate (ESR) [5, 17, 27, 29] and C-reactive protein [20] [21] [22] 30] have been observed in cases of oral PG. Blood work can be useful to exclude infectious causes and sexually transmitted diseases (ex.: syphilis, herpes, etc.) and to investigate for hematological disorders such as leukemia, myelodysplastic syndromes and refractory anemia with ringed sideroblasts [17] . Autoimmune pathologies can be investigated using serological studies and other pertinent diagnostic tests.
Differential Diagnosis
Oral PG can resemble many different entities such as mucosal tuberculosis, oral manifestations of Crohn's disease, granulomatosis with polyangiitis, oral squamous cell carcinoma, necrotizing sialometaplasia, oral involvement by T cell lymphoma, traumatic ulcerative granuloma with stromal eosinophilia (TUGSE), tertiary syphilis, neutropenic ulcers, recurrent major aphthous ulcers, and deep fungal infections (histoplasmosis, mucormycosis, cryptococcosis, blastomycosis). The characteristic features of these conditions are detailed in Table 3 [41] [42] [43] [44] [45] . The diagnosis of PG is primarily based on recognition of the characteristic morphology and evolution of the lesion, the presence of an underlying systemic disease (if any) and, the exclusion of other disease processes using proper diagnostic tools. Although histopathological features of oral PG are non-specific, they can be useful for excluding other pathological conditions with a similar clinical appearance.
Other neutrophilic dermatoses such as Behçet's disease and Sweet's Syndrome (SS or acute febrile neutrophilic dermatosis) should also be investigated. SS has a distinct clinical presentation that allows differentiating it from PG. Patients are febrile and present erythematous welldefined and asymmetrical plaques or papules on the skin [46] . Histopathology shows absence of vasculitis, a diffuse perivascular and nodular neutrophilic infiltrate, and various degrees of edema [46, 47] . Mucosal involvement is rare. The diagnosis of Behçet's disease is based on the identification of one major (2 points) and two minor (1 point each) criteria as suggested by the International Criteria for Behçet's disease for a total score of 4 and over [48] . Major criteria include recurrent oral aphthous ulcerations, while minor criteria include recurrent aphthous-like genital ulcers, uveitis, retinal vasculitis, and cutaneous lesions such as erythema nodosum, pseudofolliculitis, papulopustular lesions or a positive pathergy test.
The controversial term Malignant Pyoderma (MP) should be avoided in cases of aggressive oral PG. Revised cases of MP have been identified as granulomatosis with polyangiitis [7, 49] .
Treatment of Oral Lesions
Treatment of the underlying systemic condition, if any, represents an integral part in the management of oral and skin lesions of PG. Systemic corticosteroids are most commonly used and constitute the first line of immunosuppressive therapy. Oral prednisone, prednisolone (0.5-1 mg/kg/day) and IV methylprednisolone (0.5-1 mg/kg/day) are all effective in treating both oral and cutaneous PG [25, 50, 51] . For the treatment of oral PG, lower dosages of corticosteroids have been effective in treating lesions and preventing relapses [14, 19, 24, 30, 52] . Intralesional triamcinolone injections can complement oral steroids or immunomodulatory drugs [18, 53] . Immunosuppressive agents such as cyclosporine A (5 mg/kg/day), tacrolimus, azathioprine, and cyclophosphamide have also been administered in combination with systemic corticosteroids to induce a prolonged remission period or to reduce treatment duration [5, 29, 54] . Cyclosporine A has been used as the only systemic therapy in some cases [18, 55] . In a recent randomized, observer-blind, parallel group, controlled trial involving 112 patients with cutaneous PG, similar remission rates were reported between groups treated with cyclosporine (4 mg/kg/day) and prednisolone (0.75 mg/kg/day) suggesting that the treatment decision should be based on patient profile and possible adverse effects [55] . Monoclonal antibodies such as Infliximab (anti-TNF-α) and Adalimumab have been suggested as secondary lines of treatment for refractory multifocal disseminated lesions or in cases of multiple organ involvement [13, 28, 56] . In patients diagnosed with inflammatory bowel disease, Infliximab is often the therapeutic drug of choice [28, 57, 58] . Some reports of treatment with thalidomide and colchicine demonstrate variable responses [5, 17, 19, 59] . In addition to systemic corticosteroids, local ulcer care is suggested to enhance patient comfort and prevent secondary microbial or fungal infections. Chlorhexidine 0.12% mouth rinse can be used to achieve this in oral PG [21, 24, 31] . Topical clobetasol propionate (Dermovate 0.05%) or Tacrolimus (Protopic 0.1 or 0.03%) can be used as adjuvants to systemic therapy to relieve symptoms [9, 23] . Surgical debridement without concomitant medically induced immunosuppression or pre-operative corticosteroids should be avoided as surgery has been demonstrated to exacerbate cutaneous PG [3, 36, 51, 56, 60] . Similarly, in oral PG, Yco et al. reported that a PG ulcer spread to the adjacent alveolar ridge after a biopsy was undertaken [10] . Recurrence of PG is always possible as 10% (2/20) of cases with oral involvement have shown relapses over a period of time without appropriate maintenance therapy [22, 30] . Low dosage corticosteroids with or without Dapsone can be used as such [14, 29, 34, 61] .
Conclusion
PG is an uncommon dermatological condition with very rare oral involvement. Few reports of oral lesions have been documented since the first description of PG by Brunsfing et al. in 1930 [62] . Considering the possible morbidity associated with this disease, recognition and early diagnosis is of great importance. Exclusion of entities with a similar clinical appearance is essential. Clinicians must consider PG as a possible diagnosis for persistent and recurrent oral ulcers of unknown etiology, especially in patients with persistent skin ulcers, an underlying systemic disease known to be associated with PG, and/or when a lesion worsens following biopsy or antibiotic therapy. To guide the clinician in the diagnosis of oral PG lesions, we propose a set of diagnostic criteria based on the important clinico-pathological features gathered from the reported cases (Table 4) .
Standardized treatment protocols for mucosal lesions are still lacking and there is no scientific evidence to support the safety of local periodontal or surgical procedures in a patient affected with PG. Surgical dental interventions must be considered as possible triggers of oral lesions in patients diagnosed with cutaneous PG. Therefore, dentists must act with precaution when considering surgery on a patient previously diagnosed with cutaneous PG as research evaluating the risks of inducing oral lesions and the therapeutic modalities to treat such iatrogenically induced lesions are non-existent. Early diagnosis, proper management and consistent follow-up are essential due to the morbidity associated with these lesions and the significant risk of relapse reported in up to 30% of affected patients [14, 24] .
